ANI Pharmaceuticals Inc (ANIP): Capital Expenditures
$13.84M
Year ended 2025-12-31
$16.48M
Trailing 12 months to 2026-06-30
+15.9%
3-year compound annual growth
+17.7%
5-year compound annual growth
+20.3%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.84M | -14.8% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $16.24M | +83.1% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $8.87M | -0.1% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $8.88M | +247.1% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $2.56M | -58.3% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $6.13M | -7.5% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $6.63M | +15.5% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $5.74M | -44.6% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $10.37M | +127.1% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $4.57M | +109.2% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $2.18M | +94.9% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $1.12M | +486.4% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $191.0K | -34.6% | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $292.0K | -59.4% | 2014-02-28, From 2012-01-01 |
| 2011-12-31 | $719.9K | n/m | 2013-02-28, From 2011-01-01 |
| 2010-12-31 | $63.4K | -61.7% | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $165.7K | n/a | 2012-03-13, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $13.84M | -14.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $310.0K | -73.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $51.44M | +13.6% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.74M | +5.3% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $13.80M | -39.7% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
Compare ANIP, HRMY, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗